CRSP CRISPR Therapeutics AG

CRISPR Therapeutics AG is a gene editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics.

$65.39  +0.90 (1.40%)
As of 09/30/2022 15:59:56 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Switzerland
Country of incorporation:  Switzerland
IPO date:  10/19/2016
Outstanding shares:  78,009,260
Average volume:  1,182,966
Market cap:   $5,030,817,177
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BDHF4K6
Valuation   (See tab for details)
PE ratio:   16.36
PB ratio:   2.25
PS ratio:   5.50
Return on equity:   13.88%
Net income %:   34.07%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy